Interim Results From the PROACT Randomized FDA IDE Trial

Reduced Anticoagulation After Mechanical Aortic Valve Replacement


Reduced Anticoagulation After Mechanical Aortic Valve Replacement:
Interim Results From the PROACT Randomized FDA IDE Trial

Narrated slide presentation from The American Association for Thoracic Surgery Annual Meeting 2013, Minneapolis, Minnesota, USA, on May 6, 2013

Contact Us for more information on the On-X® Plus 1.5 Aortic Heart Valve.

Onxlti Responsive Menu
Menu